Clinical Trial Update: To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating the efficacy and safety of ALC-2203 in acute bronchitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• ALC-2203

Snippet

Sponsor: Korea Arlico Pharm. Co., Ltd | Conditions: Acute Bronchitis | Phase 2 | Status: COMPLETED